Concepedia

Jesse Siffledeen

JS

Statistics

Publications

19

Citations

1.9K

H-Index

17

Active since

2003

Affiliations

University of Alberta(Current)

University of Calgary

AbbVie (United States)

University of Toronto

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Jesse Siffledeen is an author at University of Alberta specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and medicine.

Publications per year

2003–2025

19

Publications

19

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 597 citations · Full text

, , +10

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · Gastroenterology · 2020 · 277 citations · Full text

, , +16

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Brian Bressler, Andrés Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis · 2021 · 147 citations · Full text

, , +16

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy

Natasha S. Stephens, Jesse Siffledeen, Xiaorong Su et al. · Journal of Crohn s and Colitis · 2012 · 124 citations · Full text

, , +17

The Frequency of Vitamin D Deficiency in Adults with Crohn’s Disease

Jesse Siffledeen, Kerry Siminoski, Hillary Steinhart et al. · Canadian Journal of Gastroenterology · 2003 · 111 citations · Full text

, , +16

1–5 of 19